Cargando…

Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes

Various theories for the hormonal basis of diabetes have been proposed and debated over the past few decades. Insulin insufficiency was previously regarded as the only hormone deficiency directly leading to metabolic disorders associated with diabetes. Although glucagon and its receptor are ignored...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Yunbo, Liu, Yang, Feng, Linlin, Sun, Siyu, Sun, Guangwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243425/ https://www.ncbi.nlm.nih.gov/pubmed/35784565 http://dx.doi.org/10.3389/fendo.2022.928016

Ejemplares similares

Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy
por: Yang, Cunqing, et al.
Publicado: (2023)

Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications
por: Körner, Meike, et al.
Publicado: (2012)

The role of aldosterone in the pathogenesis of diabetic retinopathy
por: Liu, Kangcheng, et al.
Publicado: (2023)

Structural and Molecular Conservation of Glucagon-Like Peptide-1 and Its Receptor Confers Selective Ligand-Receptor Interaction
por: Moon, Mi Jin, et al.
Publicado: (2012)

The relationship between HMGB1 and autophagy in the pathogenesis of diabetes and its complications
por: Yang, Kun, et al.
Publicado: (2023)

Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?
por: Conceição-Furber, Ellen, et al.
Publicado: (2022)

Ferroptosis and its potential role in gestational diabetes mellitus: updated evidence from pathogenesis to therapy
por: Zhao, Yan, et al.
Publicado: (2023)

It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
por: Oberle, Megan M., et al.
Publicado: (2019)

The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy
por: Augustine, Josy, et al.
Publicado: (2021)

Decreased expression of Glucagon-like peptide-1 receptor and Sodium-glucose co-transporter 2 in patients with proliferative diabetic retinopathy
por: Chen, Hui, et al.
Publicado: (2022)

The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms
por: Zhao, Chenhe, et al.
Publicado: (2017)

The Role of the Immune System in the Pathogenesis of Diabetic Complications
por: Virella, Gabriel, et al.
Publicado: (2014)

Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review
por: Xie, Zeyu, et al.
Publicado: (2023)

A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia
por: Lobato, Carolina B., et al.
Publicado: (2020)

Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
por: Wong, Chloe, et al.
Publicado: (2021)

Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data
por: Dong, Shichao, et al.
Publicado: (2022)

The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells
por: Marzook, Amaara, et al.
Publicado: (2021)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Circulating bile acid profile characteristics in PCOS patients and the role of bile acids in predicting the pathogenesis of PCOS
por: Yu, Jie, et al.
Publicado: (2023)

The role of microRNAs in erectile dysfunction: From pathogenesis to therapeutic potential
por: Song, Jingyu, et al.
Publicado: (2022)

Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy
por: Du, Xiaohui, et al.
Publicado: (2022)

Intestinal Growth in Glucagon Receptor Knockout Mice Is Not Associated With the Formation of AOM/DSS-Induced Tumors
por: Hunt, Jenna Elizabeth, et al.
Publicado: (2021)

Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
por: Yang, Jing, et al.
Publicado: (2022)

Plasticity in the Glucagon Interactome Reveals Novel Proteins That Regulate Glucagon Secretion in α-TC1-6 Cells
por: Asadi, Farzad, et al.
Publicado: (2019)

Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test
por: Morettini, Micaela, et al.
Publicado: (2021)

The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis
por: Dedrick, Sandra, et al.
Publicado: (2020)

Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus
por: Guo, Xinyang, et al.
Publicado: (2023)

Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota
por: Wang, Ying, et al.
Publicado: (2021)

Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications
por: March, Christine A., et al.
Publicado: (2021)

A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
por: Zhao, Li, et al.
Publicado: (2018)

Role of Endocrine-Disrupting Engineered Nanomaterials in the Pathogenesis of Type 2 Diabetes Mellitus
por: Priyam, Ayushi, et al.
Publicado: (2018)

Non-Coding RNAs and Extracellular Vehicles: Their Role in the Pathogenesis of Gestational Diabetes Mellitus
por: Zhang, Tie-Ning, et al.
Publicado: (2021)

The role of glucagon after bariatric/metabolic surgery: much more than an “anti-insulin” hormone
por: Pérez-Arana, Gonzalo-Martín, et al.
Publicado: (2023)

Role of Glucagon-Like Peptide-1 Receptor Agonists on the Weight Loss of Individuals With Type 2 Diabetes: A Systematic Review
por: Irfan, Huma, et al.
Publicado: (2023)

Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves’ Ophthalmopathy
por: Wang, Yan, et al.
Publicado: (2022)

Utilization of glucagon-like peptide-1 receptor agonists in children and adolescents in China: a real-world study
por: Yan, Yilong, et al.
Publicado: (2023)

Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis
por: Dai, Yuzhao, et al.
Publicado: (2021)

Inflammation in the pathogenesis of microvascular complications in diabetes
por: Nguyen, Dung V., et al.
Publicado: (2012)

Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
por: Ke, Xiangyu, et al.
Publicado: (2021)

Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
por: Paternoster, Silvano, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t7s4713qfdivlbnkqhnma72df9